Herbal medicinal products in the European Union - AESGP
Herbal medicinal products in the European Union - AESGP
Herbal medicinal products in the European Union - AESGP
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Summary<br />
It can be demonstrated that Council Directive 92/27/EEC on <strong>the</strong> labell<strong>in</strong>g has been<br />
implemented by all Member States.<br />
VII.6.2 Application of Council Directive 92/27/EEC to <strong>Herbal</strong> Medic<strong>in</strong>al<br />
Products<br />
National authorities were asked if Council Directive 92/27/EEC also applies to herbal<br />
<strong>medic<strong>in</strong>al</strong> <strong>products</strong>. Their replies are summarised below.<br />
Austria<br />
The Medic<strong>in</strong>es Law also applies to herbal <strong>medic<strong>in</strong>al</strong> <strong>products</strong>.<br />
Belgium<br />
As under <strong>the</strong> terms of <strong>the</strong> abridged licens<strong>in</strong>g procedure <strong>the</strong> <strong>in</strong>dication should be <strong>in</strong>troduced<br />
by <strong>the</strong> statement “This herbal <strong>medic<strong>in</strong>al</strong> product is <strong>in</strong>dicated <strong>in</strong> ….”, <strong>the</strong> <strong>medic<strong>in</strong>al</strong> product<br />
is always identified as a herbal <strong>medic<strong>in</strong>al</strong> product. Under <strong>the</strong> full application procedure,<br />
<strong>the</strong>re is no specific requirement for herbal <strong>medic<strong>in</strong>al</strong> <strong>products</strong>. The labell<strong>in</strong>g of herbal (non<strong>medic<strong>in</strong>al</strong>)<br />
<strong>products</strong> should be reported to <strong>the</strong> M<strong>in</strong>istry of Public Health.<br />
Denmark<br />
The national legislation implement<strong>in</strong>g Council Directive 92/27/EEC also applies to natural<br />
remedies [DK 3]. Natural <strong>medic<strong>in</strong>al</strong> <strong>products</strong> must have <strong>the</strong> supplementary labell<strong>in</strong>g<br />
“Natural Medic<strong>in</strong>al Product”. The labell<strong>in</strong>g of natural remedies does not have to be reported<br />
to <strong>the</strong> Danish Medic<strong>in</strong>es Agency.<br />
No specific rules apply to laxatives with plant <strong>in</strong>gredients apart from <strong>the</strong> fact that <strong>the</strong>y must<br />
be labelled with a statement that <strong>the</strong>y should not be used for more than one week.<br />
F<strong>in</strong>land<br />
Adm<strong>in</strong>istrative Regulation 5/93 entered <strong>in</strong>to force on 1 January 1994, as part of <strong>the</strong> <strong>European</strong><br />
Economic Area (EEA) harmonisation process. Applications for market<strong>in</strong>g authorisations<br />
submitted after that date had to <strong>in</strong>clude proposals for label and package leaflet texts. The<br />
package leaflet should be <strong>in</strong> F<strong>in</strong>nish and Swedish. It should be written us<strong>in</strong>g clear language<br />
that is understandable to <strong>the</strong> consumer. Its <strong>in</strong>formation should be based on <strong>the</strong> approved<br />
summary of product characteristics. The outer package of a <strong>medic<strong>in</strong>al</strong> product must bear <strong>the</strong><br />
<strong>in</strong>dication(s) and normal dosage as well as any o<strong>the</strong>r necessary <strong>in</strong>formation. If <strong>the</strong><br />
<strong>medic<strong>in</strong>al</strong> product is <strong>in</strong>dicated for children, <strong>the</strong> dosage for children should also be shown.<br />
Products that have not been approved for use by children should be marked “Not for<br />
children”.<br />
Regard<strong>in</strong>g “old” herbal <strong>medic<strong>in</strong>al</strong> <strong>products</strong>, <strong>the</strong> implications of Council Directive 92/27/EEC<br />
will be taken <strong>in</strong>to consideration at <strong>the</strong> time of renewal of <strong>the</strong> market<strong>in</strong>g authorisation. This<br />
process started <strong>in</strong> 1995 and is scheduled to be f<strong>in</strong>ished by 1999.<br />
The text “Rohdosvalmiste - Naturmedel” (“natural remedy”) must always be <strong>in</strong>cluded i n<br />
labell<strong>in</strong>g for herbal <strong>medic<strong>in</strong>al</strong> <strong>products</strong>.<br />
There are no specific labell<strong>in</strong>g requirements for certa<strong>in</strong> <strong>products</strong> such as laxatives.<br />
France<br />
The package leaflet mentions <strong>the</strong> <strong>the</strong>rapeutic class of <strong>the</strong> product. <strong>Herbal</strong> <strong>medic<strong>in</strong>al</strong> <strong>products</strong><br />
mention <strong>the</strong> herbal orig<strong>in</strong> of <strong>the</strong> <strong>products</strong> or <strong>the</strong> fact that <strong>the</strong>y belong to phyto<strong>the</strong>rapy, although<br />
this is not mandatory.<br />
Germany<br />
Council Directive 92/27/EC is applicable to all <strong>medic<strong>in</strong>al</strong> <strong>products</strong>, <strong>in</strong>clud<strong>in</strong>g herbal<br />
<strong>medic<strong>in</strong>al</strong> <strong>products</strong>. Patient <strong>in</strong>formation leaflets are compulsory for newly registered<br />
89